Vitafol Ultra By Exeltis USA Overview & Drug Interactions

Check For Interactions With Vitafol Ultra

Supplement: Vitafol Ultra by Exeltis USA

Vitafol Ultra Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Vitafol Ultra by Exeltis USA

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Pregnant and Lactating
Minimum serving Sizes:
1 Softgel Capsule(s)
Maximum serving Sizes:
1 Softgel Capsule(s)
UPC/BARCODE 306420093302

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin A
1100 IU
Vitamin A 14%
Vitamin C
30 mg
Vitamin C 50%
Vitamin D
1000 IU
Vitamin D 250%
Vitamin E
20 IU
Vitamin E 67%
Thiamine
1.6 mg
Thiamin 94%
Riboflavin
1.8 mg
Riboflavin 90%
Niacin
15 mg
Niacin 75%
Vitamin B6
2.5 mg
Vitamin B6 100%
Folate
1 mg
Folate 125%
Folic Acid
0.4 mg
Folate
L-Methylfolate Calcium
0.6 mg
Vitamin B9 (5-Methyltetrahydrofolate)
Vitamin B12
12 mcg
Vitamin B12 150%
Iron
29 mg
Iron 161%
Iodine
150 mcg
Iodine 100%
Magnesium
20 mg
Magnesium 4%
Zinc
25 mg
Zinc 167%
Copper
2 mg
Copper 100%
Algal Oil Blend
415 mg
Algal Oil --
Docosahexaenoic Acid
200 mg
DHA (Docosahexaenoic Acid)

Other Ingredients:
Gelatin
Sorbitol
Glycerin
Soybean Oil
yellow Beeswax
USP purified Water
Lecithin
FD&C Blue #1
Titanium Dioxide
Ethyl Vanillin
May contain
Forms
  • Ascorbyl Palmitate
  • Corn Oil
  • DL-Alpha-Tocopherol
  • high Oleic Sunflower Oil
  • Tocopherols


Label Statments:


Formula
- Prenatal Supplement with 200 mg DHA
- Prenatal Supplement with 200 mg DHA
- Usage: Vitafol Ultra provides vitamin, mineral, and DHA supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother, including individuals with known allergies to fish.
General Statements
- Unit dose pack RX 0642-0093-30
- How supplied: Vitafol Ultra is available as a dark blue, oval shaped softgel capsule imprinted "EV0093". Available in Box of Unit-Dose pack of 30 (5 child resistant blister cards of 6 softgel capsules), 0642-0093-30 and as professional samples 0642-0093-03.
- See package insert for full prescribing information
FDA Statement of Identity
- Dietary Supplement
Precautions
- Contains: Soy.
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or a Poison Control Center immediately.
Formulation
- Vitafol Ultra does not contain fish, fish oils, fish proteins or fish byproducts.
- Small, tolerable and complete with key nutrients for a healthy pregnancy.
Suggested/Recommended/Usage/Directions
- Directions for use: Before, during and after pregnancy, one softgel capsule daily, or as directed by a physician.
Storage
- Store at room temperature, approximately 15 degrees -30 degrees C (59 degrees - 86 degrees F), avoid excessive heat, light and moisture.
Brand IP Statement(s)
- Copyright 2020 Exeltis USA, Inc. Vitafol is a trademark of Exeltis USA, Inc. U.S. Patent No. 8,183,227 Metafolin is a trademark of Merck KGaA, Darmstadt, Germany. U.S. Patent No. 6,441,168B1; 5,997,915, 6,254,904; 6,808,725; 7,172,778 and 7,674,490
- U.S. Patented

Brand Information

See all products by this brand

Distributed By
Name Exeltis USA, Inc.
City Florham Park
State NJ
ZipCode 07932
Phone Number 1-877-324-9349
Web Address www.exeltisUSA.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.